---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-190006"
form_type: "8-K"
ticker: "KYMR"
cik: "0001815442"
company_name: "Kymera Therapeutics, Inc."
filed_at: "2022-07-08T23:59:59+00:00"
generated_at: "2026-06-24T18:37:43.564680+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Kymera appoints Leigh Morgan to Board of Directors and Compensation Committee

## Summary
- Leigh Morgan appointed as Class II director effective July 6, 2022; term expires at 2025 annual meeting.
- Board determined she is independent under Nasdaq listing standards.
- Ms. Morgan also appointed to Compensation Committee; committee now includes Morgan, Albers, Maraganore, Nicholson.
- She will receive standard non-employee director compensation; no material transactions disclosed.
- No changes to Audit or Nominating and Corporate Governance Committees.

## SEC filing metadata
- accession: 0001193125-22-190006
- form_type: 8-K
- ticker: KYMR
- cik: 0001815442
- company_name: Kymera Therapeutics, Inc.
- filed_at: 2022-07-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815442/000119312522190006/0001193125-22-190006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815442/000119312522190006/d550029d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-190006
- JSON: https://secwatch.observer/filing/0001193125-22-190006.json
- Plain text: https://secwatch.observer/filing/0001193125-22-190006.txt

## Key facts
- Executive change
  Leigh Morgan was appointed as Director at Kymera Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Leigh Morgan to join the Board, effective as of July 6, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1815442/000119312522190006/0001193125-22-190006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.